SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-009863
Filing Date
2017-05-09
Accepted
2017-05-09 16:15:08
Documents
3
Period of Report
2017-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K Q1 2017 ER orex-8k_20170509.htm 8-K 40188
2 EX-99.1 orex-ex991_6.htm EX-99.1 280267
3 GRAPHIC g20170509172956903194.jpg GRAPHIC 23525
  Complete submission text file 0001564590-17-009863.txt   354028
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33415 | Film No.: 17826580
SIC: 2834 Pharmaceutical Preparations